USSTOCK.TODAY
After-Market
Log in Sign up

Arcturus Therapeutics Records $18.3 Million in Third Quarter Revenue

The Motley Fool +1 · ·by G4L

ARCT
ARCT Arcturus Therapeutics Holdings Inc
$9.39 -1.05%
View chart & analysis →
  1. 1Arcturus Therapeutics reported revenue of $18.3 million in the third quarter.
  2. 2Arcturus Therapeutics' cash balance for the third quarter is $184.8 million.
  3. 3This includes $12 million received from CSL Seqirus during the first nine months of 2026 under termination and settlement agreements.

So what's the key point?

Arcturus Therapeutics earned $18.3 million in revenue during the third quarter. The company also received money through contracts, leaving it with a healthy cash balance.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Kodiak AI Q3 revenue surges 286% as autonomous driving technology advances The Motley Fool +1 · 4d agoBig Digital Energy executes strategy to pivot from Bitcoin mining to AI infrastructure The Motley Fool +1 · 4d agoHA Sustainable Infrastructure Capital Achieves Over $1 Billion in Transactions in Q3 The Motley Fool +1 · 4d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news